Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from TSURUHA Holdings ( (JP:3391) ).
TSURUHA Holdings has disclosed the consolidated financial results for the nine months ended November 30, 2025 of its newly acquired, now wholly owned subsidiary, WELCIA Holdings, following WELCIA’s delisting on December 1, 2025. WELCIA reported a 6.1% year-on-year increase in net sales to ¥1,010.4 billion and double-digit growth in operating and ordinary income, but net income attributable to owners of parent fell 17.3% to ¥12.2 billion, with earnings per share declining accordingly; total assets rose to ¥640.9 billion while the equity ratio softened to 39.9%, indicating growth accompanied by a slight weakening in capital structure that TSURUHA must manage as it integrates WELCIA’s large-scale operations.
The most recent analyst rating on (JP:3391) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on TSURUHA Holdings stock, see the JP:3391 Stock Forecast page.
More about TSURUHA Holdings
TSURUHA Holdings Inc. operates a major Japanese drugstore chain, offering pharmaceuticals, daily necessities, cosmetics, and health-related products through a nationwide retail network. The company is expanding its presence in the domestic drugstore and healthcare retail market, including through strategic acquisitions such as WELCIA HOLDINGS CO., LTD., another large drugstore group.
Average Trading Volume: 2,010,674
Technical Sentiment Signal: Buy
Current Market Cap: Yen1292.8B
For a thorough assessment of 3391 stock, go to TipRanks’ Stock Analysis page.